Higher leptin levels were associated with chronic widespread pain among patients with RA, even after adjusting for age, BMI, and sex.
4h
The Brighterside of News on MSNLow-cost dopamine sensor transforms Parkinson's, Alzheimer's, cancer careNeurotransmitters are essential to your body's intricate neural system. Among them, dopamine stands out for its profound ...
Company to commercialize PanCystPro, including establishing an early access program and completing a clinical utility trial ...
1d
News Medical on MSNDo prenatal antibiotics weaken breast milk immunity? A new study aims to find outA new study will investigate whether prenatal antibiotic use impairs breast milk immune function and disrupts neonatal gut ...
Rapid tests could be used to diagnose Chagas disease in resource-limited areas, according to a study led by the Barcelona Institute for Global Health (ISGlobal). The results of this research, ...
Esoteric Testing Market Research Report In 2022, the global esoteric testing market was valued at $24.2 billion and projected reach $68.5 b ...
The allergy diagnostics market is expanding rapidly due to the growing prevalence of allergic diseases. Additionally, worsening environmental conditions, including declining air quality in ...
Amicus is focused on delivering significant long-term revenue growth and anticipates surpassing $1 billion in total sales in 2028. The Company anticipates continuing to grow its current commercial ...
This valuable study reports on the critical role of ANKRD5 (ANKEF1) in sperm motility and male fertility. However, the supporting data remain incomplete. This work will be of interest to biomedical ...
BioMarin Pharmaceutical Inc. ( NASDAQ: BMRN) Q4 2024 Earnings Conference Call February 19, 2025 4:30 PM ET Traci McCarty - Head of IR Alexander Hardy - President and CEO Brian Mueller - EVP and CFO ...
This valuable work presents how PRDM16 plays a critical role during colloid plexus development, through regulating BMP signaling. Solid evidence supports the context-dependent gene regulatory ...
Applied DNA Sciences, Inc. (NASDAQ: APDN) Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results